Evaluation of Single Only Sestamibi Positive Foci in Patients with Secondary hyperparathyroidism

dc.contributor.authorAktas, A
dc.contributor.authorGencoglu, A.
dc.contributor.authorMoray, G.
dc.contributor.authorHaberal, M.
dc.contributor.orcID0000-0002-3462-7632en_US
dc.contributor.researcherIDAAJ-8097-2021en_US
dc.date.accessioned2022-06-22T06:18:02Z
dc.date.available2022-06-22T06:18:02Z
dc.date.issued2021
dc.identifier.endpageS565en_US
dc.identifier.issn1619-7070en_US
dc.identifier.issueSUPPL 1en_US
dc.identifier.startpageS564en_US
dc.identifier.urihttp://hdl.handle.net/11727/7094
dc.identifier.volume48en_US
dc.identifier.wos000709355002119en_US
dc.language.isoengen_US
dc.relation.journalEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEvaluation of Single Only Sestamibi Positive Foci in Patients with Secondary hyperparathyroidismen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: